Utsunomiya, Japan Clinical Trials

A listing of Utsunomiya, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 28 clinical trials
A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in combination with a topical corticosteroids in Japanese participants with atopic dermatitis.

Dokkyo Medical University Hospital
 (6.5 away) Contact site
  • 0 views
  • 15 May, 2021
  • +36 other locations
IMFINZI Study in Patients With Extensive Stage Small Cell Lung Cancer

To capture safety(FN) when IMF is administered to patients with extensive stage small cell lung cancer in clinical practice after launch

Research Site
 (0.7 away) Contact site
  • 0 views
  • 13 Jun, 2021
  • +38 other locations
Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)

This is a multi-center observational study of atezolizumab combination therapy in patients with unresectable, advanced and recurrent non-small cell lung cancer(NSCLC) or extensive disease small cell lung cancer(ED-SCLC). 800 patients in NSCLC cohort and 400 patients in ED-SCLC cohort will be enrolled in this trial to assess the efficacy and …

Dokkyo Medical University Hospital
 (6.5 away) Contact site
  • 0 views
  • 26 Jan, 2021
  • +72 other locations
Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis

The objective of this study is to investigate the safety and effectiveness in routine clinical practice and actual clinical setting for all patients with rheumatoid arthritis (RA) treated with peficitinib.

Site JP00009
 (8.2 away) Contact site
  • 2 views
  • 10 Jun, 2021
  • +46 other locations
Forxiga HF General Drug Use-Results Study

To capture safety when Forxiga is administered to patients with HF in clinical practice after launch

Research Site
 (0.7 away) Contact site
  • 0 views
  • 09 Jun, 2021
  • +42 other locations
Brilinta Clinical Experience Investigation

To confirm the following safety topics in patients to be treated with BRILINTA tablets 60 mg or 90 mg (hereinafter referred to as "BRILINTA") in clinical practice in the post-marketing phase. Profile and incidence of ADRs The CEI will be conducted to collect data of the events, especially focusing on …

Research Site
 (0.7 away) Contact site
  • 248 views
  • 13 Jun, 2021
  • +31 other locations
International Guillain-Barr Syndrome Outcome Study

International GBS Outcome Study (IGOS) is a study conducted by the members of the Inflammatory Neuropathy Consortium (INC) and Peripheral Nerve Society (PNS) on disease course and outcome in Guillain-Barr syndrome (GBS). The IGOS aims to identify clinical and biological determinants and predictors of disease course and outcome in individual …

Dokkyo Medical Univeristy
 (0.7 away) Contact site
  • 1279 views
  • 16 Mar, 2021
  • +147 other locations
Special Drug Use-results Surveillance of Tabrecta Tablets

This study is an uncontrolled, primary data collection-based observational study to be conducted as a central registration system, multicenter special drug-use results surveillance. As an all-case study, this study will collect all patients treated with Tabrecta in a specified post-marketing period. The observation period of each patient is up to …

Novartis Investigative Site
 (6.5 away) Contact site
  • 0 views
  • 11 Jun, 2021
  • +11 other locations